Abstract
The treatment of homozygous beta thalassaemia in Papua New Guinea during the period 1980-85 is reviewed. The results showed that the average pre-transfusion haemoglobin was 4.5 g/dl. Evidence of hypersplenism, based on spleen size or annual blood requirement, was present in all patients by age 3-4 years. Mean age of death was less than 9 years. These results are compared with previously published results of therapies from countries with more intensive treatment regimes. It is concluded that supertransfusion and hypertransfusion regimes both offer significant improvements, in duration and quality of life, upon the currently followed protocol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
